Adamek RJ et al. |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection. |
1995 |
Am. J. Gastroenterol. |
pmid:7801936
|
|
FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11363096
|
Savarino V et al. |
Helicobacter pylori eradication and reinfection. |
1995 |
Lancet |
pmid:7783564
|
Weits J and Sprenger HG |
[Surgical treatment of lymphadenitis caused by non-tuberculous mycobacteria in children]. |
1995 |
Ned Tijdschr Geneeskd |
pmid:8524431
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Adamek RJ et al. |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection]. |
1995 |
Dtsch. Med. Wochenschr. |
pmid:7889816
|
Xu G et al. |
[Effect of clarithromycin on macrophage functions]. |
1995 |
Kansenshogaku Zasshi |
pmid:7594777
|
Gelber RH et al. |
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice. |
1995 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:7602221
|
Milde P et al. |
Cutaneous bacillary angiomatosis in a patient with chronic lymphocytic leukemia. |
1995 |
Arch Dermatol |
pmid:7543264
|
Nightingale SD et al. |
Clarithromycin-induced mania in two patients with AIDS. |
1995 |
Clin. Infect. Dis. |
pmid:7548513
|
Matsiota-Bernard P et al. |
Mycobacterium genavense infection in a patient with AIDS who was successfully treated with clarithromycin. |
1995 |
Clin. Infect. Dis. |
pmid:7548515
|
Citron DM et al. |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children. |
1995 |
Clin. Infect. Dis. |
pmid:7548597
|
Ishii K et al. |
A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters. |
1995 |
Biol. Pharm. Bull. |
pmid:7550125
|
Harris AW et al. |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605863
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Yousfi MM et al. |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605865
|
Chevalley GF et al. |
[Uveitis associated with rifabutin treatment. Apropos of 3 patients]. |
1995 |
Klin Monbl Augenheilkd |
pmid:7609395
|
Blum AL et al. |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy]. |
1995 |
Leber Magen Darm |
pmid:7609589
|
Lacassin F et al. |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695324
|
Labenz J and Börsch G |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7733070
|
Forné M et al. |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. |
1995 |
Am. J. Gastroenterol. |
pmid:7733075
|
Tebas P et al. |
Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. |
1995 |
Clin. Infect. Dis. |
pmid:7742453
|
Teare JP et al. |
Pseudomembranous colitis following clarithromycin therapy. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:7743311
|
Pollak PT et al. |
Delirium probably induced by clarithromycin in a patient receiving fluoxetine. |
1995 |
Ann Pharmacother |
pmid:7655131
|
Truffot-Pernot C et al. |
Clarithromycin is inactive against Mycobacterium tuberculosis. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593032
|
Schütze K and Hentschel E |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin. |
1995 |
Z Gastroenterol |
pmid:8600661
|
Tseng AL and Walmsley SL |
Rifabutin-associated uveitis. |
1995 |
Ann Pharmacother |
pmid:8573961
|
Moayyedi P et al. |
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574714
|
Fujioka T et al. |
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574733
|
Deltenre M et al. |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574734
|
Fukuda Y et al. |
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574735
|
Graham DY |
Clarithromycin for treatment of Helicobacter pylori infections. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574737
|
Takimoto T et al. |
Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574739
|
Pavlopoulou J et al. |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children. |
1995 |
J Chemother |
pmid:8904139
|
Yoshizawa A et al. |
[Legionella pneumonia diagnosed by urinary antigen detection]. |
1995 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:7791279
|
Cheng B |
Preventing opportunistic infections. |
1995 |
PI Perspect |
pmid:11362422
|
Lounis N et al. |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793860
|
Fattorini L et al. |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793873
|
|
Abbott files SNDA for MAC prophylaxis. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11362606
|
Cohen Y et al. |
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793882
|
Pierce M |
Another perspective on MAC prophylaxis. Interview by Gordon Nary. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11362746
|
Furney SK et al. |
Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793895
|
Archange YR et al. |
Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11362747
|
Brown BA et al. |
Clarithromycin-induced hepatotoxicity. |
1995 |
Clin. Infect. Dis. |
pmid:7795060
|
|
Physician's aggressive preventive therapy differs. |
1995 |
AIDS Alert |
pmid:11362774
|
Raffi F et al. |
Breakthrough cerebral toxoplasmosis in patients with AIDS who are being treated with clarithromycin. |
1995 |
Clin. Infect. Dis. |
pmid:7795062
|
|
New drug applications sought. |
1995 |
AIDS Alert |
pmid:11362777
|
Smart T |
Cryptosporidiosis at ICAAC. |
1995 |
GMHC Treat Issues |
pmid:11362913
|
Sharma PK and Tami TA |
AIDS: lessons from the last decade and prospects for the future. |
1995 |
Ear Nose Throat J |
pmid:7796740
|
|
Researchers find new drugs to fight MAC. |
1995 |
AIDS Alert |
pmid:11362925
|